Catalog name Description price
R-M1-8643 DMG-PEG2000-α-GalNAc DMG-PEG2000-α-GalNAc/DMG-PEG2000-alpha-N-acetylgalactosamine/1,2-dimyristoyl-rac-glycero-3-PEG2000-alpha-N-acetylgalactosamine/1,2-dimyristoyl-rac-glycero-3-PEG2000-α-GalNAc have targeted drug delivery, surface modification for enhanced biocompatibility, or facilitating specific cellular interactions. price>
R-M1-8698 Retinol-PEG2000-(3-Mercaptopropionic acid) Retinol-PEG2000-3-Mercaptopropionic acid might offer several potential advantages, such as increased solubility of retinol, better pharmacokinetic profile, and attachment points for other functional groups or biomolecules. This conjugate could be used in drug delivery or targeted therapy, as well as in the development of novel retinol-based formulations for various biomedical applications. price>
R-M1-8731 DMG-PEG2000-GALA DMG-PEG2000-Galactose/1,2-Dimyristoyl-sn-glycerol-methoxypolyethylene glycol2000-Galactose/Galactose-PEG2000-DMG/1,2-Dimyristoyl-sn-glycerolPEG2000-Galactose is a compound that combines the benefits of DMG and PEG with the targeting capabilities of galactose. This conjugate has potential applications in targeted drug delivery, where it specifically recognizes and binds to cells expressing galactose receptors, such as liver cells or certain types of cancer cells, improving the delivery of therapeutic agents to these cells. price>
R-M1-8738 N3-PEG2K-CE6 Azide-PEG2K-chlorin e6/N3-PEG2K-chlorin e6/CE6-PEG2K-N3/Chlorin e6-PEG2K-N3/N3-PEG2K-CE6 combines the azide-alkyne click chemistry, the versatile properties of PEG, and the photodynamic therapy capabilities of CE6 to enable specific delivery and targeted photodynamic therapy applications in biomedical research and clinical settings. price>